Glycotest

Aged Diagnostics

The company develops non-invasive blood tests to diagnose liver disease and stage fibrosis for healthcare providers and patients.

Glycanostics

This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.

Hepta Bio

This company develops AI-powered blood tests for chronic liver disease diagnostics to assist clinicians and pharmaceutical companies with patient identification and monitoring.

Levels Diagnostics

This company develops protein biomarker tests to help medical professionals diagnose infectious diseases and detect early-stage liver cancer from blood samples.

InterVenn BioSciences

This company develops glycoproteomic diagnostic tests and an AI-driven analysis platform for clinicians and biopharmaceutical partners to improve disease detection and treatment.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Guardant Health

The company develops blood-based tests to detect and monitor cancer for patients, healthcare providers, and biopharmaceutical researchers.